NCT04667507View on ClinicalTrials.gov

Pharmacokinetics of Aqueous Dexamethasone

PHASE4CompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

October 31, 2021

Study Completion Date

June 22, 2022

Conditions
PharmacokineticsAqueous DexamethasoneInflammatory Cytokine Response
Interventions
DRUG

Dexamethasone Ophthalmic implant

Dexamethasone ophthalmic insert 0.4 mg for intracanalicular use

Trial Locations (1)

18702

Bucci Laser Vision, Wilkes-Barre

All Listed Sponsors
lead

Frank A. Bucci, Jr., M.D.

OTHER

NCT04667507 - Pharmacokinetics of Aqueous Dexamethasone | Biotech Hunter | Biotech Hunter